Welcome to our dedicated page for BF SEC filings (Ticker: BF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Brown-Forman’s story starts in a charred oak barrel, but the numbers that matter to investors live in the company’s SEC filings. From how long Jack Daniel’s whiskey ages to the currency impact on tequila sales, each document captures details you won’t find on the bottle label. If you have ever searched for Brown-Forman insider trading Form 4 transactions or wondered why barrel inventories shift quarter to quarter, you know the complexity hidden behind the heritage.
Stock Titan delivers those insights instantly. Our platform posts every Brown-Forman quarterly earnings report 10-Q filing, Brown-Forman annual report 10-K simplified, and Brown-Forman 8-K material events explained within minutes of hitting EDGAR. AI-powered summaries translate technical footnotes on agave pricing into plain language, while real-time alerts flag Brown-Forman Form 4 insider transactions real-time and other Brown-Forman executive stock transactions Form 4. Need to assess marketing spend trends? Our dashboards link line-items to narrative sections so you can move from data to decision in one view.
Whether you’re comparing margins across whiskey and tequila segments, reviewing the Brown-Forman proxy statement executive compensation, or simply understanding Brown-Forman SEC documents with AI, this page keeps you ahead. Use the built-in models for Brown-Forman earnings report filing analysis, export tables for valuation work, and set watchlists for supplier-cost disclosures. Complex regulations stay behind the scenes—what you see are clear answers to real investor questions, with every filing type covered and continuously updated.
Brown-Forman reported mixed first-quarter fiscal 2026 results with modest declines in top-line and profitability while pursuing cost realignment. Net sales were $924 million, down 3% year-over-year, driven by the Sonoma-Cutrer divestiture, foreign exchange headwinds, and lower used-barrel sales, partially offset by higher volumes and distributor inventory builds. Gross profit totaled $552 million (down 2%) and gross margin improved to 59.8% from 59.4%. Operating income was $260 million, down 7%, reflecting foreign exchange, the absence of a prior-year franchise tax refund, restructuring costs, and lower gross profit. Diluted EPS was $0.36, down 13% year-over-year. The company recognized $60 million of restructuring and other charges to date and expects $60–$70 million in aggregate. Cash and cash equivalents were $471 million at July 31, 2025 (about 54% held overseas). Management reiterated fiscal 2026 outlook: organic net sales and organic operating income declines in the low-single-digit range; effective tax rate ~21%–23%; and capital expenditures of $125–$135 million.
Brown-Forman (BF) filed a Form 4 disclosing that EVP & CFO Leanne D. Cunningham received a stock appreciation right (SAR) covering 75,105 Class B shares on 07/24/2025. The SAR carries an exercise price of $31.15, becomes exercisable on 05/01/2028, and expires on 04/30/2035. No common shares were bought or sold; the filing records only the new derivative grant. After the award, Cunningham directly holds 75,105 derivative securities and no change is reported for her non-derivative ownership. The transaction appears to be routine long-term incentive compensation and does not materially affect Brown-Forman’s share count or control structure.
